Observational studyCardiovascular diabetology2017

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.

Chia-Yu Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.